Pharma Excipients

News on Pharma Excipients

Suspensions of antibiotics in self-emulsifying oils as a novel approach to formulate eye drops with substances which undergo hydrolysis in aqueous environment

The aim of this study was to develop eye-drops with cefuroxime (CEF) sodium or vancomycin (VAN) hydrochloride, antibiotics that are instable in water. Anhydrous self-emulsifying oils (SEO) are proposed as a carrier and antibiotics are suspended. In the contact with tear fluid, the formulation should transform into emulsion, with fast dissolution of…

Why gene therapies must go virus-free

Gene therapies have made spectacular progress in delivering new cures for previously intractable disease, but they remain the world’s most expensive treatments. Now companies are replacing the virus in gene therapies with new delivery…

Transformative Materials for Interfacial Drug Delivery

Abstract Drug delivery systems (DDS) are designed to temporally and spatially control drug availability and activity. They assist in improving the balance between on-target therapeutic efficacy and off-target toxic side effects. DDS aid in…

MEGGLE USA Inc. appoints Lewis Jackson as new CEO

PRESS RELEASE, 14th June, 2023 MEGGLE USA Inc. a global leader in pharmaceutical excipients, announced the appointment of Lewis Jackson as its new Chief Executive Officer. The experienced business leader will succeed Ruth Leinenbach…